| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |